ClinicalTrials.gg
CompletedNCT03412279Updated Jun 28, 2019

Validation of Hausa Oswestry Disability Index, Numeric Pain Rating Scale, Roland-Morris Disability Questionnaire, SF-12 Health Survey, Pain Catastrophizing Scale, Fear-Avoidance Beliefs Questionnaire,Global Rating of Change Scale and Back Beliefs Questionnaire in Low Back Pain Patients

An observational study in Chronic Low Back Pain, sponsored by Bayero University Kano, Nigeria. Completed at 1 site in Nigeria. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-06-28.

Sponsored by Bayero University Kano, Nigeria · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Oswestry Disability Index (ODI), Numeric Pain Rating Scale, Roland-Morris Disability Questionnaire (RMDQ), SF-12 Health Survey, Pain Catastrophizing Scale (PCS), Fear-Avoidance Beliefs Questionnaire (FABQ), Global Rating of Change Scale and Back Beliefs Questionnaire (BBQ) are important and widely used validated patient self-reported measures commonly used in clinical trials and health research involving patients with low back pain (LBP). However, to date, validated Hausa versions of these tools are unavailable for use despite not only Hausa language is commonly spoken in Nigeria but in other parts of the world.

The purpose of this study is to perform, using evidence-based guidelines, translation, cultural adaptation and validation of the ODI, NPRS, RMDQ, SF-12 health survey, FABQ, PCS, GROC and BBQ into Hausa language among patients with LBP in Northern Nigeria.

Read the detailed description

This study will test the psychometric properties (i.e validity; reliability, and ceiling effect) of the ODI-H, NPRS, RMDQ-H, SF-12-H, FABQ-H, PCS-H, GROC and BBQ-H in Hausa-speaking patients with LBP. Rural and urban participants with LBP will be recruited purposively. Copies of the translated Hausa versions of the NPRS, ODI, RMDQ, SF-12, FABQ, PCS, BBQ as well as VAS for pain and disability will be self or interviewer-administered. Lumbopelvic mobility using finger-floor distance test (FFD) will be also measured. The Hausa versions of the ODI, NPRS, RMDQ, SF-12, FABQ, PCS, GROC and BBQ will be administered again a week after.

Data will be analysed using descriptive, correlation, and factorial analysis on IBM SPSS (version 23.0) at alpha level of 0.05.

02

Conditions studied

  • Chronic Low Back Pain

Browse trials for

Keywords

  • Chronic Low Back Pain
  • Oswestry Disability Index
  • Numeric Pain Rating Scale
  • Roland Morris Disability Questionnaire
  • SF-12 Health Survey
  • Fear-Avoidance Beliefs Questionnaire
  • Pain Catastrophizing Scale
  • Global Rating of Change Scale
  • Back Beliefs Questionnaire
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's enrollment of 200 is above the median of 100 across 481 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

Bayero University Kano, Nigeria is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with CLBP attending either rural or urban physiotherapy clinics in Kano State, Northern Nigeria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female between 18 and 70 years old.
  • Nonspecific low back pain lasting for more than 12 weeks.
  • Resident in the selected rural and urban communities in Kano State Nigeria.
  • Ability to read/understand English or Hausa language.

Exclusion criteria

Exclusion Criteria:

  • Previous history of back surgery.
  • Spine pathology (e.g. tumor, infection, fracture)
  • Severe cognitive impairment
  • Impaired capacity to be interviewed
  • Current pregnancy
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (actual)
Patient registry
No

Interventions

  • BehavioralApplication of the initial evaluation

    Initial evaluation involves the application of Hausa ODI, NPRS, RMDQ, SF-12, PCS, GROC, BBQ, VAS for pain and disability, and FFD.

  • BehavioralFinal application of instruments

    Application of the Hausa versions of ODI, NPRS, RMDQ, SF-12, PCS, GROC and BBQ one week after initial evaluation

06

What researchers measure

Primary outcomes

  1. Change in functional disability

    Functional disability will be measured by the Hausa Oswestry disability index (ODI-H). The questionnaire consists of 10 items with each item having six statements. All scores are summed, then multiplied by two to obtain the index (range 0 to 100) with higher score indicating greater disability.

    Time frame: Baseline and 1 week after baseline

  2. Change in pain intensity

    Pain intensity will be measured by the Hausa Numeric Pain Rating Scale (NPRS-H). The score ranges from 0 to 10, with 0 indicating "No Pain" and 10 "Worst Imaginable Pain".

    Time frame: Baseline and 1 week after baseline

  3. Change in functional disability

    Functional disability will be measured by the Hausa Roland-Morris Disability Questionnaire (RMDQ-H). The score ranges from 0 to 24, with 0 indicating no disability and 24 maximum disability.

    Time frame: Baseline and 1 week after baseline

  4. Change in quality of life

    Quality of life will be measured using the Hausa SF-12 Health Hurvey (SF-12-H). The questionnaire consists of 12 items questioned weighted and summed to provide physical and mental health scores (PCS and MCS). The two composite scores are computed using the scores on twelve questions that range from 0 to 100, with higher score indicating better health.

    Time frame: Baseline and 1 week after baseline

  5. Change in fear-avoidance beliefs

    Fear-avoidance beliefs will be measured by the Hausa fear avoidance beliefs

    Time frame: Baseline and 1 week after baseline

  6. Change in pain catastrophization

    Pain catastrophization will be measured by the Hausa Pain Catastrophizing Scale (PCS-H). The scale consists of 13 items rated on 5-point ordinal scale (0-5).The total score ranges from 0-52 with higher score indicating more catastrophic thoughts.

    Time frame: Baseline and 1 week after baseline

  7. Change in back beliefs

    Back pain beliefs will be evaluated by the Hausa Back Beliefs Questionnaire (BBQ-H). The questionnaire consists of 14 items with 9 items ranked on a 5 point scale and used to calculate a final score from 9 to 45. Higher scores are indicative of better LBP beliefs and indicate the potential of a better ability to cope with LBP.

    Time frame: Baseline and 1 week after baseline

  8. Change in perceived recovery

    Perceived recovery will be evaluated by the Hausa Global Rating Change of Scale (GROC-H). The scale is an 11-point scale ranging from -5 to +5 with a mid-point (0) representing " no change", a left anchor (-5) representing "Very much Worse" and a right anchor (+5) representing "Completely Recovered".

    Time frame: Baseline and 1 week after baseline

Secondary outcomes

  1. Change in pain Intensity

    Pain Intensity will be measured by 100 mm Visual Analogue Scale (VAS-P), in which 0 represents "no pain" and 10 represents "worst pain imaginable".

    Time frame: Baseline only

  2. Change in disability

    Disability will be measured by 100 mm Visual Analogue Scale (VAS-D), in which 0 represents "no disability" and 10 represents "severe disability".

    Time frame: Baseline only

  3. Change in mobility of the spine and pelvis

    The finger-floor distance test (FFD) measures mobility of both the whole spine and the pelvis in the overall motion of bending forward.

    Time frame: Baseline only

07

Study locations

1 site
  • Murtala Muhammad Specialist Hospital, Wudil General Hospital, Rano General Hospital, Kura General Hospital, and Dawakin-Kudu General Hospital
    Kano, 700, Nigeria
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2018 to primary completion in Jan 2019, 12 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2018
First posted
Jan 26, 2018
StartActual
Jan 1, 2018
Primary completionActual
Jan 31, 2019
CompletionActual
Jan 31, 2019
Last update
Jun 28, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03412279
Lead sponsor
Bayero University Kano, Nigeria
Responsible party
Aminu A. Ibrahim (Principal Investigator, Bayero University Kano, Nigeria) — Principal investigator
First posted
Jan 26, 2018
Start date
Jan 1, 2018
Primary completion
Jan 31, 2019
Completion
Jan 31, 2019
Last update
Jun 28, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion